SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease.

Wagner A, Garner-Spitzer E, Schötta AM, Orola M, Wessely A, Zwazl I, Ohradanova-Repic A, Weseslindtner L, Tajti G, Gebetsberger L, Kratzer B, Tomosel E, Kutschera M, Tobudic S, Pickl WF, Kundi M, Stockinger H, Novacek G, Reinisch W, Zielinski C, Wiedermann U

Open source

DOI: 10.3389/fimmu.2022.889138
Published: 2022
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2022.889138,
  title = {SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease.},
  author = {Wagner A and Garner-Spitzer E and Schötta AM and Orola M and Wessely A and Zwazl I and Ohradanova-Repic A and Weseslindtner L and Tajti G and Gebetsberger L and Kratzer B and Tomosel E and Kutschera M and Tobudic S and Pickl WF and Kundi M and Stockinger H and Novacek G and Reinisch W and Zielinski C and Wiedermann U},
  year = {2022},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2022.889138},
  url = {https://doi.org/10.3389/fimmu.2022.889138}
}

RIS

TY  - JOUR
TI  - SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease.
AU  - Wagner A
AU  - Garner-Spitzer E
AU  - Schötta AM
AU  - Orola M
AU  - Wessely A
AU  - Zwazl I
AU  - Ohradanova-Repic A
AU  - Weseslindtner L
AU  - Tajti G
AU  - Gebetsberger L
AU  - Kratzer B
AU  - Tomosel E
AU  - Kutschera M
AU  - Tobudic S
AU  - Pickl WF
AU  - Kundi M
AU  - Stockinger H
AU  - Novacek G
AU  - Reinisch W
AU  - Zielinski C
AU  - Wiedermann U
PY  - 2022
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2022.889138
UR  - https://doi.org/10.3389/fimmu.2022.889138
ER  -

APA

A, W., E, G., AM, S., M, O., A, W., I, Z., A, O., L, W., G, T., L, G., B, K., E, T., M, K., S, T., WF, P., M, K., H, S., G, N., W, R., C, Z., & U, W. (2022). SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2022.889138

Source records

pubmed · retrieved 2026-09-27T14:38:12.365Z
europe-pmc · retrieved 2026-09-27T14:38:12.387Z
doaj · retrieved 2026-09-27T14:38:12.362Z